New Biotech Concept Has These Stocks Gaining Investors’ Attention

Typically, the stock market slows down towards the end of summer, but this year that has not been the case.  Big pharma is weighing in on clinical stage companies as smaller biotechnology companies are benefiting.  Moves by the FDA have brought even more attention to the industry. The recent collaboration between Affimed (AFMD) and Roche (RHHBY)/Genentech showed the market that tens of millions of dollars, … Continue reading New Biotech Concept Has These Stocks Gaining Investors’ Attention

Biotech Stocks: Closing Out The Summer Strong

Heading into the last few days of summer, it is bittersweet.  August has been a month of gains for the biotechnology sector as the ETF’s have been on fire. Yesterday, the Health Care SPDR ETF (XLV) hit new highs, for the fourth trading session in a row.  The fund has gained nearly 12% over the past three months while the S&P Pharmaceuticals ETF (XPH) is … Continue reading Biotech Stocks: Closing Out The Summer Strong

3 Biotech Stocks Trending This Week

The number mergers and acquisitions in the biotech sector has started to move closer to that of all-time highs of 2016. Last year, M&A deals in the sector totaled around $200 billion, led by deals from heavyweights Johnson & Johnson’s (JNJ) and Gilead Science (GILD). Analysts remain confident that this year should only exceed those numbers. This year has already started with a bang, as Big Pharma continues … Continue reading 3 Biotech Stocks Trending This Week

Biotech Stocks Moving On Clinical Trial News

The Nasdaq iShares Biotechnology Index (IBB) has recently been on an uptrend, touching its 52-week high off the open this morning.  The ETF rose more than 1.86% during Tuesday morning’s trading, setting the stage for several other biotech stocks to follow its lead. Furthermore, several other ETF’s tracking the sector were on the move during this morning’s session. The Health Care SPDR (XLV) recorded new highs while the S&P … Continue reading Biotech Stocks Moving On Clinical Trial News

3 Marijuana Stocks Signing Supply Agreements

Ever since major alcohol conglomerate Constellation Brands (STZ) announced its plans to further raise its stake in Canopy Growth Corp. (CGC), to 38%, the marijuana industry has been a tear.  The momentum that we are seeing has been like no other, and by the look of it, things are just starting to heat up. Other alcohol makers and distributors are fighting for a piece of marijuana industry … Continue reading 3 Marijuana Stocks Signing Supply Agreements

Friday’s Top Biotech Picks

As this week’s political woes endure, it appears investors are still more concerned with the economy and corporate earnings, rather than President Trump’s legal issues. Although equities have slightly dropped, for the most part, they are still standing strong. The S&P 500 ETF (SPY) closed the day 0.1% lower on Thursday after changing between small gains and losses, while the Dow Jones Industrial Average ETF (DIA) took in a … Continue reading Friday’s Top Biotech Picks

4 Health Care Stocks To Watch

Over the last year, the health care sector has generated a positive performance and analysts predict that the numbers should only continue to improve. Most companies throughout the sector have strong balance sheets while their stocks are offering pleasant dividends to their investors. Elevated demand for health care services and products due to an aging population which calls for more wide-ranging drug treatments and medical … Continue reading 4 Health Care Stocks To Watch

3 Biotech Stocks Capitalizing On Industry Momentum

Once again, the biotechnology sector is heading higher on Tuesday.  The SPDR S&P Biotech ETF (XBI), iShares NASDAQ Biotechnology Index ETF (IBB) and Health Care SPDR ETF (XLV) are all green today. This continues to support the fact that biotech stocks have enjoyed respectable gains this year. The NASDAQ Biotechnology Index (IBB) reached new highs this year and has seen a 20 percent increase over … Continue reading 3 Biotech Stocks Capitalizing On Industry Momentum

3 Marijuana Stocks Moving On Recent News

By 2022, the North American legal marijuana revenue is forecast to amount $28.9 billion accounting for 90% of the global legal marijuana market, according to The State of Legal Marijuana Markets, 6th Edition. The report also indicated that sales will reach $47 billion over the next decade. As the marijuana market continues to bud, companies are racing expand their operations to meet increasing demands. In less … Continue reading 3 Marijuana Stocks Moving On Recent News

Pot Stock In Canada Are Getting A Lot Of Interest; Here’s Why

Typically the industry for marijuana stocks is quiet during the summer months. This year, however has seen a surge in pot stocks during late August. As the legalization of recreational marijuana in Canada looms, some blue chip companies have taken notice. Both companies in the alcohol space, Constellation Brands (STZ) and Molson Coors Brewing Company (TAP) have made big money bets on companies within the … Continue reading Pot Stock In Canada Are Getting A Lot Of Interest; Here’s Why